Parkinsonism is associated with altered primary motor cortex plasticity in frontotemporal dementia–primary progressive aphasia variant

F, Di Stasio; L, Marsili; F, Asci; A, Conte; A, Trebbastoni; C, De Lena; A, Berardelli; A, Suppa; A, Fabbrini
Abstract:
In frontotemporal dementia (FTD), the behavioral variant (bv-FTD) and nonfluent variant of primary progressive aphasia (nfv-PPA) reflect a prominent neurodegenerative involvement of the frontal lobe networks, which may include the premotor and motor areas and thus cause heterogeneous clinical symptoms including parkinsonism. With the technique of transcranial magnetic stimulation, we investigated long-term potentiation– and long-term depression–like plasticity in the primary motor cortex of bv-FTD and nfv-PPA patients, with and without parkinsonism, by using the theta-burst stimulation (TBS) protocol. We applied the intermittent TBS and continuous TBS in 20 FTD patients and 18 age-matched healthy subjects. Results were also compared with those achieved in a cohort of age-matched patients with Parkinson's disease. The responses to TBS were abnormal in FTD patients with parkinsonism. By contrast, the TBS induced normal responses in patients with both nfv-PPA and bv-FTD without parkinsonism. Finally, responses to TBS were comparable in patients with FTD with parkinsonism and patients with Parkinson's disease. We provide evidence of abnormal primary motor cortex long-term potentiation–/long-term depression–like plasticity in patients with FTD and parkinsonism suggesting neurodegenerative processes in the corticobasal ganglia-thalamo-cortical motor networks in these patients.
Patologie/Applicazioni:
Anno:
2018
Tipo di pubblicazione:
Articolo
Parola chiave:
stimolazione magnetica transcranica; theta burst; demenza; afasia; corteccia frontotemporale; plasticità; Parkinson
Testata scientifica:
Neurobiology of Aging
Nota:
Applicazione del trattamento TBS intermittente e TBS continuo in 20 pazienti FTD (con demenza frontotemporale) e 18 soggetti sani di pari età. Evidenza di potenziamento anormale della corteccia motoria primaria a lungo termine.
DOI:
10.1016
Hits: 2191

La nostra storia

GEA soluzioni si affaccia nel 2013 al mercato della strumentazione medicale di alto livello tecnologico ma la sua storia parte da più lontano, clicca qui per approfondire.  

GEA SOLUZIONI SRL
via Issiglio 95/10, Torino
Tel.: 011 5821948 / 011 4463853
Fax: 011 0433281
Email: info @ geasoluzioni.it

P. IVA IT11696920013
REA TO1233648

EU-Cookies

Copyright © 2024 GEA SOLUZIONI SRL. Tutti i diritti riservati.

Search